DOCSLIB.ORG

Changes in H5N1 Influenza Virus Hemagglutinin Receptor Binding Domain Affect Systemic Spread

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Changes in H5N1 Influenza Virus Hemagglutinin Receptor Binding Domain Affect Systemic Spread Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread Hui-Ling Yena, Jerry R. Aldridgea, Adrianus C. M. Boona, Natalia A. Ilyushinaa, Rachelle Salomona, Diane J. Hulse-Posta, Henju Marjukia, John Franksa, David A. Boltza, Dorothy Bushb, Aleksandr S. Lipatova, Richard J. Webbya, Jerold E. Rehgb, and Robert G. Webstera,1 aDivision of Virology, Department of Infectious Diseases and bDepartment of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105 Contributed by Robert G. Webster, November 6, 2008 (sent for review August 14, 2008) The HA of influenza virus is a receptor-binding and fusion protein that specimens outside the respiratory tract, including blood, cere- is required to initiate infection. The HA receptor-binding domain brospinal fluid, intestine, feces, placenta, and a fetus (16–20). determines the species of sialyl receptors recognized by influenza The mechanism of systemic spread of H5N1 viruses in mammals viruses. Here, we demonstrate that changes in the HA receptor- has not been established, although detection of virus in blood binding domain alter the ability of the H5N1 virus to spread system- (18, 21) or nerves (22) suggests possible routes. ically in mice. The A/Vietnam/1203/04 (VN1203) and A/Hong Kong/ We and others have found that A/Vietnam/1203/04 (VN1203) 213/03 (HK213) viruses are consistently lethal to domestic chickens virus, whose HA recognizes synthetic ␣2,3-linked sialyl receptor, is but differ in their pathogenicity to mammals. Insertion of the VN1203 highly pathogenic in the ferret and mouse models, whereas A/Hong HA and neuraminidase (NA) genes into recombinant HK213 virus Kong/213/03 (HK213) virus, whose HA recognizes both ␣2,3- expanded its tissue tropism and increased its lethality in mice; con- linked and ␣2,6-linked synthetic sialyl receptors, is less lethal (8, 9, versely, insertion of HK213 HA and NA genes into recombinant 23, 24). Surface glycoproteins have also been reported to play a role VN1203 virus decreased its systemic spread and lethality. The VN1203 in the pathogenicity of H5N1 viruses isolated in Hong Kong in 1997 and HK213 HAs differ by 10 aa, and HK213 HA has shown greater (11, 25), H7N7 virus isolated in the Netherlands (26), and the H1N1 binding affinity for synthetic ␣2,6-linked sialyl receptor. Introduction 1918 pandemic virus (27). We hypothesized that changes in the HA of an S227N change and removal of N-linked glycosylation at residue receptor binding domain might modulate the virulence of H5N1 158 increased the ␣2,6-binding affinity of VN1203 HA. Recombinant viruses in mammals by affecting the spread of virus from the VN1203 virus carrying the S227N change alone or with the residue- respiratory tract to other tissues. 158 glycosylation site removed showed reduced lethality and sys- temic spread in mice but not in domestic chickens. Wild-type VN1203 Results virus exhibited the greatest efficiency in systemic spread after intra- VN1203 HA and Neuraminidase Increase the Virulence of HK213 in muscular inoculation and in infection of mouse bone marrow-derived Mice. The VN1203 virus spreads systemically in inoculated mice and dendritic cells and conventional pulmonary dendritic cells. These ferrets whereas the HK213 virus is detected largely in their respi- results show that VN1203 HA glycoprotein confers pathogenicity by ratory tracts (8, 9, 23, 24). To determine whether the HA and facilitating systemic spread in mice; they also suggest that a minor neuraminidase (NA) of VN1203 contribute to its systemic spread, change in receptor binding domain may modulate the virulence of we first investigated the tissue tropism of HK213 virus carrying H5N1 viruses. VN1203 HA or VN1203 HA and NA. HK213, HK213xVN1203HA, and HK213xVN1203HANA recombinant viruses grew to compara- dendritic cell ͉ H5N1 ͉ pathogenesis ͉ mice bletitersinvitro(Table S1), and one 50% mouse lethal dose (MLD50) in BALB/cJ mice was 4,295, 413.3, and 41.8 pfu, respec- he HA glycoprotein of influenza A virus is a type I transmem- tively. Therefore, the lethality of HK213 virus was increased one log Tbrane protein that binds to sialic acid residues on target-cell by inserting VN1203 virus HA and two logs by inserting VN1203 glycoproteins or glycolipids (1). The receptor-binding domain is HA and NA. Furthermore, Ϸ40% of mice inoculated with located at the HA membrane distal end, where the 130-loop, HK213xVN1203HA or HK213xVN1203HANA virus, but none of the 220-loop, 190-helix, and other conserved residues (Y98, W153, mice inoculated with HK213, developed neurological signs (hind H183, Y195) form the receptor-binding site (1, 2). HA is a limb paralysis or convulsion). The lung titers of HK213 and host-range determinant, because human and avian influenza virus HK213xVN1203HANA virusesdifferedonday1(P ϭ 0.0174, HAs preferentially recognize ␣2,6- and ␣2,3-linked sialyl receptors, Tukey’s test) but were comparable on days 3, 5, and 7 after respectively (3, 4). In addition to the terminal sialic-acid linkages, inoculation (P ϭ 0.0802, 2-way ANOVA) (Fig. 1A). internal linkages, as well as fucosylation, sulfation, and sialylation at HK213xVN1203HA and HK213xVN1203HANA viruses were de- the inner oligosaccharides, also determine receptor-binding affinity tected in brain or blood, suggesting that infection was not contained and specificity (2, 5). Despite their preferential recognition of in the mouse lungs (Fig. 1A). The results suggest that the HA ␣2,3-linked sialyl receptors, highly pathogenic H5N1 avian influ- glycoproteins of VN1203 contribute to viral spread from the enza viruses are able to infect humans and cause severe disease. respiratory tract. Glycan-array profiling has shown differences between seasonal human influenza virus and H5N1 viruses (2, 6), but current techniques are at an early stage to map the glycans in tissues, and Author contributions: H.-L.Y., A.C.M.B., R.J.W., J.E.R., and R.G.W. designed research; H.- it is not known whether differences in glycan recognition affect L.Y., J.R.A., A.C.M.B., N.A.I., H.M., J.F., D.A.B., D.B., A.S.L., and J.E.R. performed research; R.S. and D.J.H.-P. contributed new reagents/analytic tools; H.-L.Y. and J.R.A. analyzed data; influenza virus pathogenicity. and H.-L.Y., J.R.A., and R.G.W. wrote the paper. The highly pathogenic H5N1 viruses are consistently lethal to The authors declare no conflict of interest. domestic chickens but differ in their pathogenicity to small 1To whom correspondence should be addressed at: Department of Infectious Diseases, St. mammals, including mice and ferrets (7–9). Although H5N1 Jude Children’s Research Hospital, 332 N. Lauderdale, Memphis, TN 38105. E-mail: virulence in mammals is known to be a polygenic trait (10–15), [email protected]. H5N1 viruses that are highly lethal to mice or ferrets commonly This article contains supporting information online at www.pnas.org/cgi/content/full/ spread systemically after intranasal inoculation (8, 9). Further- 0811052106/DCSupplemental. more, H5N1 virus or RNA has been isolated from human © 2008 by The National Academy of Sciences of the USA 286–291 ͉ PNAS ͉ January 6, 2009 ͉ vol. 106 ͉ no. 1 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0811052106 Downloaded by guest on September 28, 2021 Table 1. Affinity of the recombinant H5N1 influenza viruses to sialyl substrates Recombinant virus Fetuin p6ЈSL p3ЈSL p3ЈSLN HK213 0.18 Ϯ 0.03 5.78 Ϯ 0.82* 1.05 Ϯ 0.21* ND VN1203 0.14 Ϯ 0.06 Ͼ100 0.23 Ϯ 0.04 1.81 Ϯ 0.22 VN1203 HAS227N 0.26 Ϯ 0.03* Ͼ100 0.13 Ϯ 0.05 6.35 Ϯ 0.34* VN1203 HAS227Nϩ158Gly⌬ 0.11 Ϯ 0.04 19.49 Ϯ 1.21* 0.17 Ϯ 0.03 6.81 Ϯ 0.29* diss ϭ mean Ϯ SE ϫ t␣,n-1 (␮M sialic acid), where t␣ is Student’s coefficient with probability ␣ ϭ 0.95, from four independent experiments. *P Ͻ 0.05. alone is not sufficient to confer preferential binding to p6ЈSL. Our results suggest that the increased binding affinity of HK213 for p6ЈSL was mediated mainly by the S227N change and the absence of N-linked glycosylation at residue 158. Introduced HA Mutations Do Not Affect Viral Growth In Vitro or Membrane Fusion pH. We assessed whether the introduced HA changes affected growth of recombinant VN1203 viruses in vitro. VN1203xHK213HANA virus was generated for comparison. The recombinant viruses grew comparably in Madin-Darby canine kidney (MDCK) cells but formed different plaque sizes (see Table S1). At a multiplicity of infection (MOI) ϭ 0.0001 pfu/cell, multistep growth curves showed comparable titers of VN1203, VN1203- Fig. 1. VN1203 HA contributes to systemic spread in mice. Virus titers in HAS227N, and VN1203-HAS227Nϩ158Gly⌬ viruses in MDCK cells lungs, brains (including olfactory bulbs), and blood of BALB/cJ mice inoculated (Fig. S1). We also evaluated whether the introduced HA mutations intranasally with 100 pfu/50 ␮L of recombinant of HK213 (A) and VN1203 (B) Ϯ would affect membrane fusion activity of the VN1203 recombinant viruses. Each data point represents the mean virus titer SD from 3 mice. *, viruses by determining the pH of syncytium formation in Vero cells. P Ͻ 0.05; , P Ͻ 0.01. ** Vero cells infected with VN1203, VN1203-HAS227N, and VN1203- HAS227Nϩ158Gly⌬ viruses formed syncytia at or below pH 5.8, 5.9, Determinants of HA Affinity for ␣2,6-Linked Sialyl Receptor. We and 5.8, respectively. Syncytium formation was observed at or below assess possible functional differences between the HK213 and pH 5.7 for the VN1203xHK213HANA virus. The results suggest that VN1203 HA glycoproteins. The two HA glycoproteins were the introduced HA mutations did not significantly impair viral shown to differ in their affinity for synthetic ␣2,3-linked 3Ј- fitness in vitro.
Load more

Recommended publications
  • A Conserved Influenza a Virus Nucleoprotein Code Controls Specific
    ARTICLE Received 8 Mar 2016 | Accepted 10 Aug 2016 | Published 21 Sep 2016 DOI: 10.1038/ncomms12861 OPEN A conserved influenza A virus nucleoprotein code controls specific viral genome packaging E´tori Aguiar Moreira1,2,3, Anna Weber1, Hardin Bolte1,2,3, Larissa Kolesnikova4, Sebastian Giese1, Seema Lakdawala5, Martin Beer6, Gert Zimmer7, Adolfo Garcı´a-Sastre8,9,10, Martin Schwemmle1 & Mindaugas Juozapaitis1 Packaging of the eight genomic RNA segments of influenza A viruses (IAV) into viral particles is coordinated by segment-specific packaging sequences. How the packaging signals regulate the specific incorporation of each RNA segment into virions and whether other viral or host factors are involved in this process is unknown. Here, we show that distinct amino acids of the viral nucleoprotein (NP) are required for packaging of specific RNA segments. This was determined by studying the NP of a bat influenza A-like virus, HL17NL10, in the context of a conventional IAV (SC35M). Replacement of conserved SC35M NP residues by those of HL17NL10 NP resulted in RNA packaging defective IAV. Surprisingly, substitution of these conserved SC35M amino acids with HL17NL10 NP residues led to IAV with altered packaging efficiencies for specific subsets of RNA segments. This suggests that NP harbours an amino acid code that dictates genome packaging into infectious virions. 1 Institute of Virology, University Medical Center Freiburg, 79104 Freiburg, Germany. 2 Spemann Graduate School of Biology and Medicine, University of Freiburg, 79104 Freiburg, Germany. 3 Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany. 4 Institute of Virology, Philipps-Universita¨t Marburg, 35043 Marburg, Germany. 5 Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15217, USA.
    [Show full text]
  • Dissecting Human Antibody Responses Against Influenza a Viruses and Antigenic Changes That Facilitate Immune Escape
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2018 Dissecting Human Antibody Responses Against Influenza A Viruses And Antigenic Changes That Facilitate Immune Escape Seth J. Zost University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons, Medical Immunology Commons, and the Virology Commons Recommended Citation Zost, Seth J., "Dissecting Human Antibody Responses Against Influenza A Viruses And Antigenic Changes That Facilitate Immune Escape" (2018). Publicly Accessible Penn Dissertations. 3211. https://repository.upenn.edu/edissertations/3211 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/3211 For more information, please contact [email protected]. Dissecting Human Antibody Responses Against Influenza A Viruses And Antigenic Changes That Facilitate Immune Escape Abstract Influenza A viruses pose a serious threat to public health, and seasonal circulation of influenza viruses causes substantial morbidity and mortality. Influenza viruses continuously acquire substitutions in the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). These substitutions prevent the binding of pre-existing antibodies, allowing the virus to escape population immunity in a process known as antigenic drift. Due to antigenic drift, individuals can be repeatedly infected by antigenically distinct influenza strains over the course of their life. Antigenic drift undermines the effectiveness of our seasonal influenza accinesv and our vaccine strains must be updated on an annual basis due to antigenic changes. In order to understand antigenic drift it is essential to know the sites of antibody binding as well as the substitutions that facilitate viral escape from immunity.
    [Show full text]
  • Safety and Immunogenicity of a Baculovirus- Expressed Hemagglutinin Influenza Vaccine a Randomized Controlled Trial
    PRELIMINARY COMMUNICATION Safety and Immunogenicity of a Baculovirus- Expressed Hemagglutinin Influenza Vaccine A Randomized Controlled Trial John J. Treanor, MD Context A high priority in vaccine research is the development of influenza vaccines Gilbert M. Schiff, MD that do not use embryonated eggs as the substrate for vaccine production. Frederick G. Hayden, MD Objective To determine the dose-related safety, immunogenicity, and protective ef- ficacy of an experimental trivalent influenza virus hemagglutinin (rHA0) vaccine pro- Rebecca C. Brady, MD duced in insect cells using recombinant baculoviruses. C. Mhorag Hay, MD Design, Setting, and Participants Randomized, double-blind, placebo-controlled Anthony L. Meyer, BS clinical trial at 3 US academic medical centers during the 2004-2005 influenza season Jeanne Holden-Wiltse, MPH among 460 healthy adults without high-risk indications for influenza vaccine. Hua Liang, PhD Interventions Participants were randomly assigned to receive a single injection of saline placebo (n=154); 75 µg of an rHA0 vaccine containing 15 µg of hemagglutinin Adam Gilbert, PhD from influenza A/New Caledonia/20/99(H1N1) and influenza B/Jiangsu/10/03 virus Manon Cox, PhD and 45 µg of hemagglutinin from influenza A/Wyoming/3/03(H3N2) virus (n=153); or 135 µg of rHA0 containing 45 µg of hemagglutinin each from all 3 components LL CURRENTLY LICENSED IN- (n=153). Serum samples were taken before and 30 days following immunization. fluenza vaccines in the United Main Outcome Measures Primary safety end points were the rates and severity of States are produced in em- solicited and unsolicited adverse events. Primary immunogenicity end points were the bryonated hen’s eggs.
    [Show full text]
  • Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/Goose/Guangdong/1/96 Lineage
    Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 62 / No. 6 June 28, 2013 Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS Introduction ............................................................................................................2 Background .............................................................................................................2 Guidelines for Working with Influenza Viruses Containing an HA from the A/goose/Guangdong/1/96 Lineage ..................................3 Conclusion ...............................................................................................................6 References ...............................................................................................................7 Front cover photo: Transmission electron micrograph of avian influenza A H5N1 viruses (gold) grown in Madin-Darby canine kidney (MDCK) cells (green). The MMWR series of publications is published by the Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30333. Suggested Citation: Centers for Disease Control and Prevention. [Title]. MMWR 2013;62(No. RR-#):[inclusive page numbers]. Centers for Disease Control and Prevention Thomas R. Frieden, MD, MPH, Director
    [Show full text]
  • Autocatalytic Activation of Influenza Hemagglutinin
    University of Pennsylvania ScholarlyCommons Department of Chemical & Biomolecular Departmental Papers (CBE) Engineering December 2006 Autocatalytic Activation of Influenza Hemagglutinin Jeong H. Lee University of Pennsylvania Mark Goulian University of Pennsylvania Eric T. Boder University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/cbe_papers Recommended Citation Lee, J. H., Goulian, M., & Boder, E. T. (2006). Autocatalytic Activation of Influenza Hemagglutinin. Retrieved from https://repository.upenn.edu/cbe_papers/83 Postprint version. Published in Journal of Molecular Biology, Volume 364, Issue 3, December 2006, pages 275-282. Publisher URL: http://dx.doi.org/10.1016/j.jmb.2006.09.015 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/cbe_papers/83 For more information, please contact [email protected]. Autocatalytic Activation of Influenza Hemagglutinin Abstract Enveloped viruses contain surface proteins that mediate fusion between the viral and target cell membranes following an activating stimulus. Acidic pH induces the influenza virus fusion protein hemagglutinin (HA) via irreversible refolding of a trimeric conformational state leading to exposure of hydrophobic fusion peptides on each trimer subunit. Herein, we show that cells expressing fowl plague virus HA demonstrate discrete switching behavior with respect to the HA conformational change. Partially activated states do not exist at the scale of the cell, activation of HA leads to aggregation of cell surface trimers, and newly synthesized HA refold spontaneously in the presence of previously activated HA. These observations imply a feedback mechanism involving self-catalyzed refolding of HA and thus suggest a mechanism similar to the autocatalytic refolding and aggregation of prions.
    [Show full text]
  • ACRONYM & GLOSSARY LIST - Revised 9/2008
    Survey & Certification Emergency Preparedness Initiative – All Hazards EMERGENCY PREPAREDNESS ACRONYM & GLOSSARY LIST - Revised 9/2008 ACRONYMS AAL Authorized Access List AAR After-Action Report ACE Army Corps of Engineers ACIP Advisory Committee on Immunization Practices ACL Access Control List ACLS Advanced Cardiac Life Support ACF Administration for Children and Families (HHS) ACS Alternate Care Site ADP Automated Data Processing AFE Annual Frequency Estimate AHRQ Agency for Healthcare Research and Quality (HHS) AIE Annual Impact Estimate AIS Automated Information System AISSP Automated Information Systems Security Program AMSC American Satellite Communications ANG Air National Guard ANSI American National Standards Institute AO Accrediting Organization AoA Administration on Aging (HHS) APE Assistant Secretary for Planning and Evaluation (HHS) APF Authorized Program Facility APHL Association of Public Health Laboratories ARC American Red Cross ARES Amateur Radio Emergency Service ARF Agency Request Form ARO Annualized Rate of Occurrence ASAM Assistant Secretary for Administration & Management (HHS) ASC Ambulatory Surgical Center ASC Accredited Standards Committee ASH Assistant Secretary for Health (HHS) ASL Assistant Secretary for Legislation (HHS) ASPA Assistant Secretary for Public Affairs (HHS) ASPE Assistant Secretary for Planning & Evaluation (HHS) ASPR Assistant Secretary for Preparedness & Response (HHS) ASRT Assistant Secretary for Resources & Technology (HHS) ATSDR Agency for Toxic Substances & Disease Registry (HHS) BARDA
    [Show full text]
  • Virology Techniques
    Chapter 5 - Lesson 4 Virology Techniques Introduction Virology is a field within microbiology that encom- passes the study of viruses and the diseases they cause. In the laboratory, viruses have served as useful tools to better understand cellular mechanisms. The purpose of this lesson is to provide a general overview of laboratory techniques used in the identification and study of viruses. A Brief History In the late 19th century the independent work of Dimitri Ivanofsky and Martinus Beijerinck marked the begin- This electron micrograph depicts an influenza virus ning of the field of virology. They showed that the agent particle or virion. CDC. responsible for causing a serious disease in tobacco plants, tobacco mosaic virus, was able to pass through filters known to retain bacteria and the filtrate was able to cause disease in new plants. In 1898, Friedrich Loef- fler and Paul Frosch applied the filtration criteria to a disease in cattle known as foot and mouth disease. The filtration criteria remained the standard method used to classify an agent as a virus for nearly 40 years until chemical and physical studies revealed the structural basis of viruses. These attributes have become the ba- sis of many techniques used in the field today. Background All organisms are affected by viruses because viruses are capable of infecting and causing disease in all liv- ing species. Viruses affect plants, humans, and ani- mals as well as bacteria. A virus that infects bacteria is known as a bacteriophage and is considered the Bacteriophage. CDC. Chapter 5 - Human Health: Real Life Example (Influenza) 1 most abundant biological entity on the planet.
    [Show full text]
  • Influenza Virus Hemagglutinin Stalk-Based Antibodies and Vaccines
    Available online at www.sciencedirect.com Influenza virus hemagglutinin stalk-based antibodies and vaccines 1 1,2 Florian Krammer and Peter Palese Antibodies against the conserved stalk domain of the activity and can readily be measured in serum using the hemagglutinin are currently being discussed as promising hemagglutination inhibition (HI) assay [3]. These anti- therapeutic tools against influenza virus infections. Because of bodies are directed against the membrane distal part of the the conservation of the stalk domain these antibodies are able to HA, the globular head domain (Figure 1a,b,d) [4,5,6 ], broadly neutralize a wide spectrum of influenza virus strains and which has a high plasticity and is subject to constant subtypes. Broadly protective vaccine candidates based on the antigenic drift driven by human herd immunity. There- epitopes of these antibodies, for example, chimeric and headless fore, antibodies that target this domain (HI-active anti- hemagglutinin structures, are currently under development and bodies) are very strain specific and quickly lose efficacy show promising results in animals models. These candidates against drifted strains. Because of this viral mechanism to could be developed into universal influenza virus vaccines that escape human herd immunity influenza virus vaccines protect from infection with drifted seasonal as well as novel have to be reformulated almost annually based on surveil- pandemic influenza virus strains therefore obviating the need for lance data from laboratories in the Northern and Southern annual vaccination, and enhancing our pandemic preparedness. hemispheres [7]. Vaccine strain prediction based on sur- Addresses veillance is a complicated and error prone process and 1 Department of Microbiology, Icahn School of Medicine at Mount Sinai, produces mismatches between circulating virus and New York, NY, USA vaccine strains from time to time which leads to a severe 2 Department of Medicine, Icahn School of Medicine at Mount Sinai, drop in efficacy of the seasonal influenza virus vaccines [8– New York, NY, USA 12].
    [Show full text]
  • Anti-HA (12CA5)
    For life science research only. Not for use in diagnostic procedures. Anti-HA (12CA5) Mouse monoclonal antibody (clone 12CA5) to a peptide epitope derived from the hemagglutinin protein of human influenza virus Cat. No. 11 583 816 001 200 ␮g (lyophilized) Cat. No. 11 666 606 001 5 mg (1 ml solution) y Version 07 Content version: April 2016 Store at Ϫ15 to Ϫ25°C 1. What this Product Does Purity The anti-HA monoclonal antibody is Ն 90% pure as determined by HPLC. Contents ␮ The antibody preparation does not contain pre- • Cat. No. 11 583 816 001: 200 g white lyophilizate servatives or stabilizers. • Cat. No. 11 666 606 001: 1 ml frozen liquid (5 mg/ml) 8 Affinity Ka = 1 × 10 /M Storage and Stability Isoelectric 6.4 If stored at Ϫ15 to Ϫ25°C, the lyophilized antibody preparations are Point stable until the expiration date printed on the label. For storage, prepare convenient aliquots and freeze them at Ϫ15 to 2. How to Use this Product Ϫ25°C. Avoid repeated freezing and thawing. 2.1 Before You Begin Lyophilized Anti-HA antibody is shipped at ambient temperature. Liquid Anti-HA antibody is shipped on dry ice. Epitope Tagging Before using Anti-HA to analyze the product of your target gene, Application incorporate the 27-base DNA sequence, which encodes the HA epi- tope, into the target gene sequence Anti-HA (12CA5) is used for the immunochemical detection of native using one of the following meth- influenza hemagglutinin protein and recombinant “epitope tagged” ods: proteins containing the HA epitope in western and dot blots, immuno- • Clone your gene of interest into a suitable bacterial or mammalian cytochemistry, and immunoprecipitation.
    [Show full text]
  • Assembly of Influenza Hemagglutinin Trimers and Its Role in Intracellular Transport
    Assembly of Influenza Hemagglutinin Trimers and Its Role in Intracellular Transport Constance S. Copeland, Robert W. Doms, Eva M. Bolzau, Robert G. Webster,* and Ari Helenius Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut 06510; * Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101. Abstract. The hemagglutinin (HA) of influenza virus posttranslational event, occurring with a half time of is a homotrimeric integral membrane glycoprotein. It ~7.5 min after completion of synthesis. Assembly oc- is cotranslationally inserted into the endoplasmic retic- curs in the endoplasmic reticulum, followed almost ulum as a precursor called HA0 and transported to the immediately by transport to the Golgi complex. A cell surface via the Golgi complex. We have, in this stabilization event in trimer structure occurs when study, investigated the kinetics and cellular location of HA0 leaves the Golgi complex or reaches the plasma the assembly reaction that results in HA0 trimer- membrane. Approximately 10% of the newly synthe- ization. Three independent criteria were used for de- sized HA0 formed aberrant trimers which were not termining the formation of quaternary structure: the transported from the endoplasmic reticulum to the appearance of an epitope recognized by trimer-specific Golgi complex or the plasma membrane. Taken to- monoclonal antibodies; the acquisition of trypsin resis- gether the results suggested that formation of correctly tance, a characteristic of trimers; and the formation of folded quaternary structure constitutes a key event stable complexes which cosedimented with the mature regulating the transport of the protein out of the en- HA0 trimer (9S20.w) in sucrose gradients containing doplasmic reticulum.
    [Show full text]
  • The Influenza Virus: Antigenic Composition and Immune Response
    Postgrad Med J: first published as 10.1136/pgmj.55.640.87 on 1 February 1979. Downloaded from Postgraduate Medical Journal (February 1979) 55, 87-97. The influenza virus: antigenic composition and immune response G. C. SCHILD B.Sc., Ph.D., F.I.Biol. Division of Viral Products, National Institute for Biological Standards and Control, Holly Hill, Hampstead, London NW3 6RB Summary capricious epidemiological behaviour of the The architecture and chemical composition of the causative virus and perhaps also the nature of the influenza virus particle is described with particular immune response in man to influenza antigens. reference to the protein constituents and their genetic control. The dominant role in infection of the surface Antigenic composition of the virus proteins - haemagglutinins and neuraminidases - Studies of the single-stranded, negative-strand, acting as antigens and undergoing variation in time RNA genome of the influenza A virus have revealed known as antigenic drift and shift is explained. The the existence of 8 species of RNA molecules (gene immuno-diffusion technique has illuminated the inter- segments) in the virus (McGeoch, Fellner and relationships of the haemagglutinins of influenza A Newton, 1976; Palese and Schulman, 1976a). viruses recovered over long periods of time. The Ho Each gene segment provides the code for one of the and H1 haemagglutinins are now regarded as a single 8 virus specific proteins synthetized in infected sub-type with H2 and H3 representing the haemag- cells. Seven of these proteins are integrated into glutinins of the 1957 and 1968 sub-types. Animal influenza virus particles. Table 1 summarizes the by copyright.
    [Show full text]
  • Hemagglutinin Immunoglobulin M (Igm) Monoclonal Antibody That Neutralizes Multiple Clades of Avian H5N1 Influenza a Virus Shuo Shen1, Geetha Mahadevappa1, Sunil K
    Journal of Antivirals & Antiretrovirals - Open Access www.omicsonline.org JAA/Vol.1 Issue.1 Research Article OPEN ACCESS Freely available online doi:10.4172/jaa.1000007 Hemagglutinin Immunoglobulin M (IgM) Monoclonal Antibody that Neutralizes Multiple Clades of Avian H5N1 Influenza A Virus Shuo Shen1, Geetha Mahadevappa1, Sunil K. Lal2 and Yee-Joo Tan1,3,* 1Collaborative Anti-viral Research Group, Institute of Molecular and Cell Biology, Singapore, 138673 2Virology Group, International Centre for Genetic Engineering & Biotechnology, Aruna Asaf Ali Road, New Delhi 110067, India 3Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597 for novel antiviral therapy and vaccination strategies. The H5N1 Abstract viruses have now appeared in at least 53 countries on three continents The hemagglutinin (HA) of influenza A virus plays an and continue to evolve and diversify. Based upon the evolution of essential role in mediating the entry of the virus into host the HA gene, the H5N1 viruses could be grouped into numerous cells. In this study, 4 HA monoclonal antibodies (MAbs) clades, representing emerging lineages and multiple genotypes (see of immunoglobulin M (IgM) isotype were generated by recent review by (Guan et al., 2009)). This continuous evolution of using recombinant full-length HA protein, which was ex- the H5N1 virus, which is endemic in the poultry population of some pressed and purified from the baculovirus-insect cell sys- countries, poises a challenge to the development of vaccine or antiviral therapy that has to remain efficient against newly emerged tem, from a H5N1 isolate (A/chicken/hatay/2004(H5N1)). antigenic variants.
    [Show full text]